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This study explored the affect expression and self-regulation capacities of 8-month-old
infants exposed in utero to psychotropic medications. This was a continuation of our
previous study conducted on the same cohort when the infants were 3months old.
Psychotropics implicated included selective serotonin reuptake inhibitors (SSRIs), and a
benzodiazepine derivative anxiolytic (clonazepam). The three comparison groups were:
control (n = 23; infants not exposed to psychotropics in utero), SSRI-alone (n = 22; infants
exposed to SSRIs only and having mothers who had a primary diagnosis of depressive
disorder without having comorbid anxiety disorder), and SSRI+ group (n = 15; infants ges-
tationally exposed to SSRIs and clonazepam and having mothers that had both clinical
depression and anxiety disorder). Using the Parent–Child Early Relational Assessment
Scale, infants were assessed in a dyadic context during free play and a structured task.
There were signiﬁcant differences in psychotropic exposed and non-exposed dyads regard-
ing infant negative affect management. There were signiﬁcant associations between the
SSRI+ group of mothers and infant negative affect. This group of mothers also showed
signiﬁcant associations with infants’ averting and avoiding behaviors in both play situations.
The SSRI-alone group was similar to the control group and showed variable associations
with infant’s positive, negative, and sobermoods unlike the SSRI+ group.Therewere no dif-
ferences in infants’ capacity for self-regulation in psychotropic exposed and non-exposed
groups. Increased awareness of these vulnerable subgroups (SSRI-alone and SSRI+) is
needed, in order to safeguard these dyads through better support systems and improved
management.
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INTRODUCTION
Affect expression and self-regulation are important skills that are
fundamental for optimal infant socio-emotional development.
These faculties can be compromised by prenatal stress and aber-
rant postnatal experiences. Infants’ affective experiences and self-
regulatory capacities can be affected in utero directly or indirectly
by a multitude of stressors ranging from maternal depression
and/or anxiety to direct placental transfer of psychotropics.
Although depression affects people of all ages, race, and sex;
women during their childbearing years are at the highest risk of
developing depression that is associated with psychiatric disor-
ders such as anxiety disorders and substance-related disorders (Le
Strat et al., 2011). Unfortunately, not all depressed/anxious preg-
nant women access timely treatment for their symptoms (Marcus,
2009). The burden of untreated maternal depression and anxiety
is borne by bothmothers and their fetuses/infants (Maughan et al.,
2007; Marcus, 2009; Bernier et al., 2010).
The effects of antenatal anxiety/depression examined in lon-
gitudinal designs are mixed. Newborns of prenatally depressed
mother showed less responsiveness to stimuli in several stud-
ies (Field, 2011). Weinberg et al. (2008) evaluated the effects of
maternal depression and panic disorder, and found that infants
belonging to these two groups showed similar “still face behavior”
as infants from non-clinical samples. One study that focused on
pregnancy-speciﬁc anxiety duringmid-pregnancy predicted lower
mental and motor developmental scores at 8months (Buitelaar
et al., 2003). The Avon Longitudinal Study (O’Connor et al., 2002)
found that antenatal maternal anxiety was associated with behav-
ioral and emotional problems in 4-year-old children. In this same
cohort, prenatal depression was associated with delayed develop-
ment in 18-month-old infants (Deave et al., 2008). Van den Bergh
and Marcoen (2004) found no signiﬁcant associations between
maternal anxiety and internalizing behaviors in 8- and 9-year-old
children as reported by their parents and caregivers. However, high
antenatal maternal anxiety was related to attention deﬁcit hyper-
activity disorder symptoms and externalizing problems in 8- and
9-year-olds in this same study.
Some researchers reported that whilst maternal depression is a
risk factor, it does not affect attachment patterns in children when
maternal depression is resolved in early childhood (Campbell
et al., 2004). It has also been found that infant interaction behav-
iors improved when interacting with a non-depressed teacher or
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father (Field, 1998). This suggests timely support for the depressed
mother is an important step toward improved child developmental
adaptation.
Evidence is accumulating, albeit mostly from animal studies,
that self-regulation processes can be disturbed prenatally. The off-
spring of prenatally stressed non-human primates demonstrated
more problems with attention and coping with novel situations
(Schneider, 1992; Clarke and Schneider, 1997).Huizink andBuite-
laar (2000) suggested that stress in humans cannot be compared
to animals in experimental research, where the routine form of
stressor is usually externally inﬂicted on the animal. However,
Oberlander et al. (2008) found that maternal depression, specif-
ically third trimester exposure to maternal depression/anxiety,
affects potential epigenetic regulation of glucocorticoid receptor
gene expression.
Of particular importance to this study is the question of
depressedmothers with comorbid diagnoses such as anxiety disor-
der. These complicated clinical situations often require therapeutic
approaches that include combinations of psychotropic medica-
tions. A study by Carter et al. (2001) found that the effects of
maternal depression were accounted for by mothers with comor-
bid diagnoses, who had less optimal interactions, and infants with
higher rates of insecurity than eithermothers with depression only
or mothers with no psychopathology.
Treating depressed/anxious pregnant mothers who seek help
can also be complicated. Pharmacotherapy still occupies the gold
standard for treatment of maternal depression. However, use of
medications during pregnancy is controversial. Some authors cau-
tioned against publication bias with regards to negative studies
on this topic (Koren and Nickel, 2011). Nevertheless, this dis-
cussion has become more relevant as use of antidepressants such
as selective serotonin reuptake inhibitors (SSRIs) is rising. In a
population-based cohort study in Netherlands, the exposure rate
to SSRIs increased from 12.2 to 28.5 pregnancies per 1000 in
8 years (Bakker et al., 2008). Safety concerns are continually being
expressed regarding the use of SSRIs, serotonin–norepinephrine
reuptake inhibitors (SNRIs), antiepileptic drugs, mood stabiliz-
ers, benzodiazepines, and antipsychotics during pregnancy (Way,
2007; Gentile and Bellantuono, 2009; Sackett et al., 2009; Tuccori
et al., 2009; Gentile, 2010).
In this study, the psychotropic medications that were investi-
gated included SSRIs, and a benzodiazepine derivative anxiolytic
(clonazepam). Therefore, further discussion will focus on these
two psychotropic agents. Use of benzodiazepines (BZD) in preg-
nancy is laden with associations with neonatal withdrawal syn-
dromes, facial clefts, and cardiac malformations (Cohen et al.,
1989; McElhatton, 1994). Research has yielded conﬂicting infor-
mation regarding the use of SSRIs during pregnancy and its
deleterious effects on the developing fetus. Several authors (Ober-
lander et al., 2004; Sackett et al., 2009; Tuccori et al., 2009) noted
signiﬁcant associations between gestational exposure to SSRIs and
pulmonary hypertension of the newborn and transient adapta-
tion syndrome. Associations between SSRI exposure and earlier
deliveries and lower Apgar scores, have also been described. Ober-
lander et al. (2004) demonstrated transient neonatal symptoms
such as mild respiratory distress and to a lesser degree hypoto-
nia following prenatal psychotropic exposure; the results were
inconclusive regarding direct causality with SSRI exposure. Our
previous ﬁndings concurredwithOberlander’s in that the addition
of clonazepam altered paroxetine absorption, thereby increasing
medication levels, and transient neonatal symptoms (Misri et al.,
2004). Recently, longer gestational exposure to SSRIs was shown to
be related to lower birth weight, respiratory distress, and reduced
gestational age (Oberlander et al., 2008). Similarly, Casper et al.
(2011) reported that the length of in utero exposure to SSRIs neg-
atively affects neonatal adjustment. Although it was shown that
SSRIs do not increase the rate of major congenital malforma-
tions in neonates (Pastuszak et al., 1993; Goldstein et al., 1997;
Misri et al., 2000; Einarson et al., 2001; Simon et al., 2002), subtle
disturbances were detected.
Studies on neurocognitive development of infants that were
exposed to SSRI or tricyclic antidepressants yield mixed results
(Nulman et al., 1997; Gentile, 2005). Casper et al. (2003) found
that SSRIs administered during fetal development may have sub-
tle effects on motor development. Mulder et al. (2011) noted
high motor activity of SSRI-exposed fetuses. However, a review
by Udechuku et al. (2010) did not ﬁnd signiﬁcant differences
on developmental outcomes between in utero SSRI-exposed and
non-exposed children.
Infant self-regulatory capacities in the context of in utero
exposure to psychotropics are not extensively reported. How-
ever, parent–child relationships are uniformly identiﬁed as playing
an important part in developing child’s self-regulatory capacity
(Schore, 1994; Bernier et al., 2010).
Finally, it is crucial to understand what exactly is implied
for the developing fetus when exposed to psychotropics. Neuro-
transmitters and neuromodulators are important for the build-
ing of neural circuitry. This function can be disturbed, with
long-term behavioral effects, by prenatal or neonatal stress and
drugs that cross placenta (Herlenius and Lagercrantz, 2001). Sero-
tonin plays a role in regulating physiological functions such as
sleep, appetite, and temperature. It is believed that serotonin
activity is present at birth and continues throughout adulthood.
Cortical serotonin receptors develop in an ontogenetic fashion
in the cerebral cortex during the postnatal period (Aitken and
Tork, 1988). SSRIs increase serotonin availability in the synap-
tic clefts and due to placental transfer; there is the possibility
of increased serotonin levels in neonates prenatally exposed to
SSRIs. However, it is not known whether this early exposure
potentiates further synaptic growthor up-regulation. Speciﬁc ben-
zodiazepine binding also occurs as early as 7 weeks post conception
and clonazepam has this ability to bind, pointing toward early
ontogeny of the central benzodiazepine receptors (Hebebrand
et al., 1988).
The current study focused on infants exposed to SSRIs and
a benzodiazepine where the key neurotransmitters involved are
serotonin and GABA. This study was a continuation of a preced-
ing study looking at affect expression in prenatally psychotropic
(SSRI and clonazepam) exposed infants. The previous study was
conducted on the same group of infants aged 3months. It was
shown that mothers with comorbid diagnoses of depression and
anxiety were more reactive in their emotional expressions to the
affect expression of their infants than were control or depressed
mothers (Reebye et al., 2002).
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In this phase of the investigation, affect expression and self-
regulation capacities of infants at 8months of age were assessed
to ﬁnd out if in utero exposure to psychotropic medications has
primed these infants for behavioral teratogenicity. Many mothers
stop nursing their infants after 3–6months for practical reasons
such as returning to work. Discontinuation of breast-feeding at
12weeks has already been identiﬁed as a risk for the return of
maternal depressive factors (Taveras et al., 2003). Study dyads were
expected to settle into a routine past this vulnerable period to allow
precise measurement of affect expression and self-regulation.
Therefore, 8months seemed a suitable cut off point for the investi-
gation of this cohort. This time period also facilitated observation
of complex social interactions betweenmothers and infants (Stern,
1995). As infants take greater part in social interactions, their emo-
tional regulation capacity increases (Posner and Rothbart, 2002).
Moreover, this 6- to 10-month stage of mother–infant relation-
ship has not yet been extensively explored, with some exceptions
(Davids et al., 1963; Buitelaar et al., 2003). This study focused on
this critical window, speciﬁcally on the capacities of affect expres-
sion and self-regulation in the gestationally SSRI-alone/SSRI+
exposed and non-exposed infants.
The a priori hypothesiswas that of three groups (controls,SSRI-
alone, and SSRI+), the infants of control mothers would be more
successful with self-regulation than infants of mothers using psy-
chotropics in pregnancy as assessed on the Parent–Child Early
Relational Assessment (PCERA) and measures of self-regulation.
In psychotropic exposed dyads, it was expected that the SSRI+
group, where infants had mothers with comorbid diagnoses that
were receiving SSRIs and an anxiolytic,would experiencemore dif-
ﬁculty with self-regulation than the infants whose mothers were
taking only SSRIs and did not have comorbid anxiety. Further-
more, it was predicted that infants of control mothers would be
able to express affect appropriately to the demands of the situation
(free play and structured play) than infants that were gestationally
exposed to psychotropics.
Infants’ postnatal affective experiences are a combination of
their individual developmentally determined contribution and
that derived from maternal affect. The outcome measures cho-
sen for this study reﬂect a combination of strategies to tap on
infants’ affective style and the mutual regulation processes in the
mother–infant context.
MATERIALS AND METHODS
The study was undertaken with the approval from the Univer-
sity of British Columbia Research Ethics Board and the Children’s
and Women’s Health Centre of British Columbia Research Ethics
Committee.
RECRUITMENT AND SAMPLE CHARACTERISTICS
Subjects for the SSRI-alone and SSRI+ groups were recruited dur-
ing pregnancy. Subjects for the non-exposed control group were
recruited from day 1 postpartum. Recruitment of SSRI-alone and
SSRI+ groups was carried out over 2 years from the outpatient
referrals to the Reproductive Mental Health Program at St. Paul’s
Hospital and British Columbia’s Women’s Hospital in Vancouver.
Eligible subjects were medically healthy women who received one
ormoreAxis I diagnoses during pregnancy.Womenwere excluded
from participating if they were abusing substances, psychotic,
suicidal, or exposed to known teratogens.
Subjects in this study were not serially approached. They were
invited from the cohort involved in our previous 3months post-
partum study. The attrition rate was very low with the withdrawal
of only one subject and one subject-changing category from the
original SSRI-alone to SSRI+ group.
Of the 60 ﬁnal participant dyads, 22 of the infants had been
exposed to SSRIs only and their mothers had a primary diag-
nosis of depressive disorder without having comorbid anxiety
disorder; these dyads made up the SSRI-alone group. Eleven of
these mothers were taking paroxetine (Paxil), seven were taking
ﬂuoxetine (Prozac), and four were taking sertraline (Zoloft). A
further 15 participant mothers were taking SSRIs and clonazepam
(Rivotril) of which, 13 were taking paroxetine and clonazepam
and 2 were taking ﬂuoxetine and clonazepam. These 15 mothers
had both clinical depression and anxiety disorder and with their
infants made up the SSRI+ group. The SSRI-alone and SSRI+
group women all remained on medication up until the end of the
study.
All subjects in the experimental group (SSRI-alone and SSRI+)
were given a mental status examination by a reproductive psychi-
atrist. The clinician also scored Hamilton Anxiety Rating Scale
(HAM-A; Hamilton, 1959), Hamilton Depression Rating Scale
(HAM-D; Hamilton, 1960), and Clinical Global Impression Scale
(CGI; Guy, 1976). Out of 37 participants in the psychotropic
exposed group, all the mothers suffered from clinical depres-
sion according to the Diagnostic and Statistical Manual of Mental
Disorders, Fourth edition (DSM-IV) criteria. The comorbid diag-
noses consisted of panic disorder, generalized anxiety disorder, and
obsessive-compulsive disorder. At the time of recruitment, there
were no mothers with the diagnosis of bipolar disorder.
A control group of non-depressed (clinically and by self-
disclosure), non-treated (psychotropic medications) healthy (no
other serious comorbid pathology) mothers and their healthy
infants (living with biological mothers) were recruited after deliv-
ery frompediatricians’clinics. Initially,128dyadswere approached
for the control group. Ninety-four of those dyads refused, were
not suitable or were difﬁcult to contact. Thirty-four dyads were
suitable; out of which we have complete data on 23 mother–
infant dyads. The research coordinator approached mothers from
this list of normal healthy pregnancies and deliveries during the
ﬁrst or second day postpartum. A screening chart review of the
antenatal birth record was performed by the research coordina-
tor prior to approaching the mother to conﬁrm the presence
or absence of any treatment for depression. Exclusionary cri-
teria included a documentation of depression or treatment for
depression. No self-report questionnaires were used initially but
a psychiatrist who was blind to study procedures provided clin-
ical assessment of control mothers at 2 and 8months postpar-
tum. HAM-D questionnaire was only scored at 2months in this
group.
Inclusion of infants of depressed/anxious mothers who were
not treated pharmacologically would have assisted our ability
to separate the effects of maternal mood from those of prena-
tal medications exposure. However, we were unable to recruit
such a group due to the nature of the referral patterns to the
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Reproductive Mental Health Program and due to Ethics Board
requirements. It should also be noted, that such a sample would
be self-selected, which could have introduced further biases (e.g.,
severity of anxiety/depressive symptoms) into the study.
This sample is representative of the population served by the
catchment areaof Children’s andWomen’sHealthCenter of British
Columbia.
PROCEDURES
In our 3-month study (Reebye et al., 2002), mother and infant
were videotaped during free play and feeding task. In this study,
mother and infant were videotaped when the infant was 8months
of age at the Biobehavioural Research Laboratory. It was decided
that structured play task would be used rather than feeding, due
to the variable feeding times of each infant.
The PCERA (Clark, 1985) was used to rate the affective and
behavioral quality of the parent–infant relationship during two
sequences: free play (where the mother was instructed to play
with her infant as she would at home) and structured play task
(a novel task where the infant was to ﬁnd hidden cubes.) Free play
and structured play task sequence lasting a total of 10min were
analyzed.
Infants were assessed on the Bayley Scales of Infant Devel-
opment at age 8months (Bayley, 1993). A reproductive psychi-
atrist interviewedmothers in the psychotropic exposed group and
scored the CGI (Guy, 1976), the HAM-D (Hamilton, 1960), and
the HAM-A (Hamilton, 1959). The reproductive psychiatrist also
clinically assessed control mothers.
Maternal measures
The HAM-D (Hamilton, 1960) is used to assess the severity of
depression. The 21-item version was used. Items are scored from
0 to 4, the higher the score, the more severe the depression. A cut
off point of 7 indicates a clinical level of depression.
The HAM-A (Hamilton, 1959) consists of 14 items. This scale
measures the severity of symptoms of anxiety, tension, palpita-
tions, breathing difﬁculties, sleep disturbances, restlessness, and
other physical symptoms. The items are scored from 0 to 4, with a
progression from none (score 0) to severe (score 4). The accepted
clinical cut off point is a total score of 14.
The CGI (Guy, 1976) is used to measure the global impression
of the patient and has a single item measured on a 7-point scale
from 1 (normal, not ill) to 7 (extremely ill).
Affect expression measures (using PCERA)
Positive infant affect variable was constructed with expressed pos-
itive infant affect, happy mood. Negative infant affect composite
variable included expressed negative affect, and irritable mood.
Positivematernal affect variablewas constructedwith expressed
positive affect, enjoyment, and pleasure. Maternal negativity com-
posite variable included expression of negative affect, displeasure,
and contingent response to negative behavior.
Maternal sensitivity duringplay interaction is a logical indicator
of healthy parent–child relationships (Welch et al., 2003) and was
therefore an appropriate measure to record for this study. As mea-
sured through PCERA, three components were scored: reads cues
and responds sensitively, quality of verbalization, and contingent
response to positive behavior.
Self-regulation measures (using PCERA)
For this study, self-regulation variables consisted of attentional,
behavioral, social, emotional, and mutual regulation (Eisenberg
et al., 2000;Calkins andFox,2002).Table 1 explains the regrouping
of variables as used in our analysis.
Table 1 | Self-regulation variables.
Infant variables Dyadic variables Maternal variables
Attentional Attentional abilities Joint attention/activity –
Persistence
Behavioral Alertness/interest – –
Passivity/lethargy
Hyperactivity
Social Social behavior of child – initiates – Quality and amount of physical contact-positive
Social behavior of child – responds Quality and amount of physical contact-negative
Avoiding/averting/resistance Quality and amount of visual contact with child
Structures and mediates environment
Emotional Positive infant affect – Expressed parental affect-positive
Negative infant affect Expressed parental affect-negative
Happy mood
Emotional lability
Mutual regulation Self-regulation Anger/hostility Contingent responsivity to child’s positive behavior
Flat/empty/constricted Contingent responsivity to child’s negative behavior
Tension/anxiety
Enthusiasm/joyfulness
Joint attention/activity
Reciprocity
Organization/regulation of interactions
State similarity
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Infant and dyadic measures
The PCERA scoring system examines up to 65 parent, child, and
dyadic variables. Each itemof the PCERA is rated on a 5-point Lik-
ert scale that offers a comprehensive description of the interaction
between parent and child, with scores of 1 and 2 indicating areas
of concern, 3 as some concern, and 4 and 5 as areas of strength.
As a result, variables measuring negative behavior (i.e., maternal
variables of expressed negative affect, displeasure, and contin-
gent response to negative behavior; infant variables of expressed
negative affect, irritable mood, apathetic/withdrawn, and sober;
and dyadic variables of ﬂat/constricted and tension/anxiety) were
effectively reverse coded. For example, while a mother show-
ing a great deal of appropriate positive affect would receive an
expressed positive affect score of 5, indicating an area of strength.
A mother showing a great deal of negative affect would receive
a score of 1 on the expressed negative affect scale, indicating
an area of weakness. High scores on PCERA variables should
thus always be interpreted as positively valenced, indicating better
functioning.
CODING PROCEDURES
Two research assistants were trained on ﬁve sequences (feed-
ing, diapering, free play, structured task, and separation–reunion
sequence) of maternal–infant interaction items on PCERA. The
training included approximately 30 h of reviewing tapes and cod-
ing with the investigator who had established inter-rater reliability
with the author of PCERA. The two research assistants who were
blind to the study rated all the tapes.
A sample of 10 tapes (20% of entire sample) were randomly
selected and rated by a trained coder who was also blind to
infant and maternal background characteristics. Inter-rater reli-
ability was established during the entire coding procedure, tak-
ing samples at the beginning and over regular intervals until
the ﬁnal coding was done on a total of 20% of the sample.
(Two coders carried one out of every ﬁve codings). This relia-
bility was maintained to 85% on feeding, structured task, and
free play segments. Random reliability checks were made on the
scores obtained through different segments on PCERA scoring
system.
Table 2 | Affect expression and self-regulation composite variables:
Cronbach’s alpha coefficients during structured play and free play.
Composite variable Range of
variable
Structured
play
Free
play
AFFECT EXPRESSION
Positive maternal affect 3–15 0.87 0.82
Maternal sensitivity 2–10 0.78 0.84
Maternal negativity 3–15 0.72 0.78
Positive infant affect 2–10 0.81 0.79
Negative infant affect 2–10 0.81 0.79
SELF-REGULATION
Social behavior of child 2–10 0.72 0.61
Positive infant affect 2–10 0.78 0.93
Affective quality of interaction 4–20 0.79 0.62
Mutuality 4–20 0.80 0.87
CONSTRUCTION OF DATA SETS AND STATISTICAL ANALYSIS
Data reduction
Composite variables were computed due to the high intercorrela-
tions between some maternal variables and some infant variables.
This allowed fewer variables and logical clustering of certain rat-
ing scales. Cronbach’s alpha (a measure of internal consistency
based on the average inter-item correlation) was calculated for
each composite variable and is shown in Table 2. Three of the
resulting composites; maternal sensitivity, positive infant affect,
and negative infant affect, thus have ranges from 2 to 10, while
positive maternal affect and maternal negativity have ranges from
3 to 15. Affective qualify of interaction and mutuality variables
have ranges from 4 to 20.
Missing data
Unfortunately, there was incomplete maternal psychiatric data.
Some subjects were missing data for three variables; the HAM-
A, HAM-D, and the CGI. The decision was taken to omit these
subjects when comparing maternal mood against the mutual reg-
ulation variables. This left 16mothers in the SSRI-alone group and
11 mothers in the SSRI+ group at 8months.
Statistical analysis
Mean values and standard deviations were calculated for every
composed maternal, infant, and dyadic variable and for each of
the three groups (control, SSRI-alone, and SSRI+) for both struc-
tured play and free play interaction sequences between mother
and infant. To determine signiﬁcant differences among groups,
ANOVA were conducted for each variable and sequence. To deter-
mine the direction and strength of the relationship between vari-
ables within each group, Kendall’s tau b correlation coefﬁcients
were calculated. Kendall’s tau b is ameasure of association between
two variables that is designed to be used with ordinal data such as
that produced by the PCERA and similar qualitative rating mea-
sures. Correlations between the three groups were determined: (a)
non-exposed control, (b) SSRI-alone, and (c) SSRI+.
RESULTS
MATERNAL DEMOGRAPHICS (Table 3)
There were no signiﬁcant differences between the three study
groups apart from years of education; mothers in the control
group had signiﬁcantly more years of education than the two
psychotropic exposed groups [F(2,56)= 4.28, p = 0.02].
INFANT CHARACTERISTICS (Table 4)
All infants were born at full term with normal birth weights
and lengths. However, there were signiﬁcant differences between
the mean infant head circumferences of the three groups
[F(2,57)= 3.24, p ≤ 0.05].
GROUP DIFFERENCES FOR AFFECT EXPRESSION AND DYADIC
VARIABLES
The group mean values and standard deviations for the control,
SSRI-alone, and SSRI+ groups were compared and only one vari-
able showed group differences: anger/hostility in the free play
situation, and group mean values were minimally discrepant even
on this variable.
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Table 3 | Maternal background demographic characteristics.
Control
(n =23)
SSRI-alone
(n =22)
SSRI+
(n =15)
Marital status
Married 22 (96%) 21 (95%) 14 (93%)
Single – 1 (5%) 1 (7%)
Divorced/separated 1 (4%) – –
Maternal age (year)a 32 (4.5) 31 (4.0) 31 (4.7)
Ethnicity
White 19 (83%) 19 (86%) 14 (93%)
Indian/Asian 3 (13%) 2 (9%) –
Native Indian – 1 (5%) –
Other 1 (4%) – 1 (7%)
Maternal education (year)a 16.2 (2.8)* 14.5 (3.0) 13.6 (2.3)
Past employment
Homemaker – 3 (14%) 3 (20%)
Professional 17 (74%) 14 (63%) 6 (40%)
Technical 2 (9%) 2 (9%) –
Other 4 (17%) 3 (14%) 6 (40%)
Medication during pregnancyb
No. of days on SSRI n/a 189.5 (32–293) 162 (56–275)
No. of days on clonazepam n/a n/a 110 (44–208)
Severity of symptoms at entrya
HAM-A – 13.37 (8.66)c 19.13 (13.97)
HAM-D – 17.84 (6.87)c 17.93 (9.68)
Severity of symptoms at 2monthsa
HAM-A – 11.89 (11.66)c 12.10 (10.74)d
HAM-D 3.52 (3.37) 9.11 (8.63)c 10.50 (10.36)d
Severity of symptoms at 8monthsa
HAM-A – 5.75 (7.10)e 15.27 (12.77)f
HAM-D – 3.44 (6.91)e 11.55 (6.49)f
aMean (standard deviation), bmedian (range), cn=19, dn=10, en=16, fn=11,
*p=0.02.
Table 4 | Infant characteristics.
Control
(n =23)
SSRI-alone
(n =22)
SSRI+
(n =15)
Sex 10M, 13F 13M, 9F 7M, 8F
Birth weight (g)a 3406 (439) 3381 (415) 3481 (422)
Gestational age (week) 39.3 (1.3) 39.6 (1.3) 39.3 (1.1)
Length at birth (cm) 51.3 (2.0) 51.6 (3.5) 51.7 (2.2)
Head circumference at birth (cm) 34.9 (1.7)* 33.8 (1.3)* 34.5 (1.0)*
BAYLEY SCALESAT 8MONTHS
Mental Development Index 99 (5.5) 100 (6.1) 97 (4.5)
Psychomotor Development Index 97 (8.6) 91 (9.5) 93 (8.6)
aMean (standard deviation), *p<0.05.
MATERNAL–INFANT AFFECT CORRELATIONS IN THE CONTROL, SSRI,
AND SSRI+ GROUPS (Table 5)
In free play, we found that mothers who belonged to the control
and SSRI-alone groups showed that their positive affect andmater-
nal sensitivity correlated to positive infant affect. However, this
pattern changed for SSRI-alone dyads when faced with external
demands and structured situation as compared to control group
dyads.
Infant sober mood as described by PCERA includes frowns,
wrinkling of the forehead, or looks of consternation. When the
infants were sober, we found that during free play, the SSRI-alone
groupofmothers displayed ahighermaternal sensitivity compared
to control group mothers. In terms of structured play, however,
control groupmothers responded with signiﬁcantly higher mater-
nal sensitivity than mothers from experimental (SSRI-alone and
SSRI+) groups.
The SSRI+ group showed a markedly different pattern from
either the control or the SSRI-alone groups. Positive infant affect
and sober mood had no signiﬁcant correlations with any of the
maternal variables in the SSRI+ group. However, strong and sig-
niﬁcant correlationswere found between infant negative affect and
all three maternal variables in both free play and structures task
situations.
SELF-REGULATION COMPONENTS AND MUTUAL REGULATION
Therewereno signiﬁcant differences among the three groups in the
variables grouped under attentional, behavioral, social, emotional,
or mutual regulation parameters.
MUTUAL REGULATION VARIABLES AND RELATIONSHIP WITH
MATERNAL MOOD (Table 6)
There were no signiﬁcant negative associations between mutual
regulation variables and maternal mood as measured by HAM-A
and HAM-D in both play situations in the three groups. Positive
associations were found in the SSRI-alone group between mater-
nal anxiety and self-regulation in the structured play, and between
maternal anxiety and affective quality of interaction in the free
play. As reported in Table 6, SSRI-alone group mothers had sub-
clinical anxiety symptoms at 8months. No signiﬁcant correlations
were found between mutual regulation infant affect component
variables and HAM-A and HAM-D scores. CGI results are not
reported in the Table as they were insigniﬁcant and the infor-
mation obtained through HAM-D and HAM-A scores deemed
sufﬁcient.
MOTHER–CHILD SOCIAL INTERACTION VARIABLES FOR THE THREE
GROUPS (Table 7)
For control group dyads, there were signiﬁcant correlations
between both the social behavior of the child composite and
the child’s avoiding, averting, and resistance behavior with the
mother’s amount and quality of negative physical contact, in struc-
tured play sequences.Mothers in the control groupwere thusmore
negative when their infants showed avoidance or resistance, how-
ever in response to children’s social overtures they reacted less
negatively. There were no signiﬁcant associations in the free play
task between the infant andmaternal social variables in the control
group.
In the SSRI-alone group, there were no relationships between
the social behavior of the child composite or the child’s avoiding,
averting, and resistance behavior and the mother’s amount and
quality of negative physical contact. The associations in the free
play situation could not be analyzed as the quality and amount of
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Table 5 | Intercorrelations (Kendall’s tau b) between maternal variables and infant variables for the three groups during structured play and free
play at 8months.
Maternal variables Control SSRI-alone SSRI+
Positive
infant
affect
Negative
infant
affect
Sober
mood
Positive
infant
affect
Negative
infant
affect
Sober
mood
Positive
infant
affect
Negative
infant
affect
Sober
mood
STRUCTURED PLAY
Positive maternal affect 0.38* 0.03 0.46* 0.34* 0.33* 0.26 0.32 0.48* −0.02
Sensitivity 0.35* −0.01 0.46* 0.31 0.25 0.24 0.18 0.50* 0.04
Negativity 0.36* 0.16 0.27 0.27 0.42* 0.07 0.34 0.47* 0.07
FREE PLAY
Positive maternal affect 0.75*** 0.14 0.51** 0.49** −0.16 0.32 0.41 0.68** 0.37
Sensitivity 0.76*** 0.26 0.52** 0.57** 0.16 0.65*** 0.21 0.57** −0.06
Negativity 0.31 0.22 0.20 0.66** 0.03 0.51** 0.28 0.80*** 0.05
*p≤0.05, **p≤0.01, ***p≤0.001.
Table 6 | Kendall’s tau b correlation coefficients between mutual regulation variables during both interaction sequences at 8months and
HAM-A and HAM-D indices at 8months for SSRI-alone and SSRI+ groups and at 2months for control group.
Mutual regulation variables Control SSRI-alone (n =16) SSRI+ (n =11)
Hamilton
Anxiety
Index
Hamilton
Depression
Index
Hamilton
Anxiety
Index
Hamilton
Depression
Index
Hamilton
Anxiety
Index
Hamilton
Depression
Index
STRUCTURED PLAY
Contingent response to child behavior: positive – −0.121 0.187 0.211 0.229 −0.092
Contingent response to child behavior: negative – 0.093 −0.097 0.016 −0.056 0.112
Self-regulation – 0.163 0.510* 0.027 −0.071 0.353
Affect quality of interaction – −0.061 0.198 0.087 −0.090 −0.339
Mutuality – −0.328 0.109 −0.015 −0.226 −0.090
FREE PLAY
Contingent response to child behavior: positive – −0.196 0.372 0.294 −0.049 0.049
Contingent response to child behavior: negative – 0.139 Constant Constant 0.259 0.065
Self-regulation – 0.141 −0.099 −0.210 −0.052 0.286
Affect quality of interaction – −0.014 0.412* −0.064 0.194 0.097
Mutuality – −0.055 −0.025 −0.316 0 0.162
*α=0.05.
Table 7 | Intercorrelations (Kendall’s tau b) between maternal social variables and infant social variables for the three groups during structured
play and free play at 8months.
Maternal variables Control SSRI-alone SSRI+
Social
behavior
of child
Avoiding,
averting,
resistance
Social
behavior
of child
Avoiding,
averting,
resistance
Social
behavior
of child
Avoiding,
averting,
resistance
STRUCTURED PLAY
Quality and amount of physical contact: negative 0.52** 0.55** 0.09 −0.07 0.37 0.61**
FREE PLAY
Quality and amount of physical contact: negative 0.46 −0.05 § § 0.53* 0.70**
*p≤0.05, **p≤0.01, ***p≤0.001, §constants.
Note: High scores indicate more functional behavior for all variables.
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negative physical contact in the free play situation was invariant in
the SSRI-alone group.
The SSRI+ group showed a different pattern of interactions. In
the structured play task, there was a positive association between
avoidant, averting, and resistant behaviors and the maternal vari-
able of quality and amount of negative physical contact, as in the
control group. However, unlike the control group, mothers in the
SSRI+ group also showed more negative physical contact when
children showed initiation of and response to social overtures and
when they were avoidant or resistance in the free play task.
DISCUSSION
AFFECT EXPRESSION
The ﬁrst phase of analysis in this cohort (Reebye et al., 2002)
indicated that the SSRI+ group (infants andmothers) showed dif-
ferent patterns of association between maternal and infant affect
expression compared to the other two groups. At 8months of
age, differential patterns of association between maternal and
infant affect occurred in all three groups, however, the control
and the SSRI-alone (depression without comorbid anxiety disor-
der) groups exhibited more similarities than differences whereas
the SSRI+ group (depression comorbid with anxiety disorder)
showed a distinct pattern. The severity of mood symptoms (anx-
iety and depression) of the SSRI+ group was not negatively or
signiﬁcantly associated with any maternal and infant interactions
variables, as showed in Table 6.
Parental management of infant negative affect is generally
more challenging as compared to management of infant pos-
itive or sober affect. This may explain why signiﬁcant differ-
ences between the three groups were found in this speciﬁc area,
as showed in Table 5. Control group mothers were able to
cope with infant negative affect in both play situations. Posi-
tive correlation between maternal negativity and negative infant
affect were found in psychotropic exposed groups. However, this
correlation was signiﬁcant in both play situations for SSRI+
group, compared to the SSRI-alone group who showed signif-
icant correlation in the structured play sequence only. Struc-
tured play placed speciﬁc demands on the dyad that are not
present in the free play situation. SSRI-alone mothers seemed
to be able to cope with infant negative affect in less demand-
ing situations, however when additional demands were posed as
in the structured play they were overwhelmed. For the SSRI+
mothers, even meager demands of the free play situation posed
challenges. This raises the possibility that the mothers in the
psychotropic exposed groups are perhaps experiencing difﬁcul-
ties in dyadic affect regulation related to infant negative affect.
They may also be experiencing difﬁculties in repairing interac-
tive errors (Gianino and Tronick, 1988; Tronick and Weinberg,
1997).
Maternal sensitivity was also signiﬁcantly and positively related
to infant negative affect in the SSRI+ group during both free and
structured play. There was little variation between the correlations
during the two different interaction sequences and we therefore
speculate that themothers in the SSRI+ group are overwhelmedby
their infants’ negative affect. By focusing exclusively on infant neg-
ative affect and perhaps becoming too intrusive, these mothers are
less able to read the infant’s cues and gain the needed information
to respond appropriately and help their infant to co-regulate their
mood.
In the SSRI+ group, there were signiﬁcant correlations between
negative infant affect and all maternal variables in both structured
and free play. SSRI+motherswhose infants were displaying higher
levels of negative affect were themselves less positive, less sensitive,
and more negative in their affect.
According to the priority hypothesis, affect regulation takes pri-
ority over other components of self-regulation such as for example
attentional and social domains (Tice et al., 2001). Negative emo-
tions therefore shift self-regulatory attempts from long-term goals
to short-term feeling states as alleviation of emotional distress
takes precedence.When the hypothesis is applied to this study, the
behaviors of mothers in the SSRI-alone and SSRI+ group can be
partially understood. These mothers may be more invested in reg-
ulating their own affect rather than regulating interactions with
their infants in demanding play situations.
There was no signiﬁcant association observed with SSRI+
mothers’ variables toward infant sober mood during both
structured and free play sequences. When infants express sober
moods, mothers in the control or SSRI-alone groups are tak-
ing some measures to respond or repair errors; SSRI+ mothers
however seem less burdened with infant sober mood. More nega-
tive infant affect expression is probably required in other to make
SSRI+ mothers react.
SELF-REGULATION
Our data did not support the hypothesis that infants who are
exposed to the psychotropics in utero and infants whose mothers
have comorbid pathologies (anxiety and depression) are more at
risk for impaired self-regulation capacities.
SOCIAL BEHAVIOR
The audience effect (where infants smile in response to pres-
ence of another) is not expected to be fully developed at age of
8months, therefore infant expressions provide important infor-
mation within the context of the mother–infant relationship. A
mother’s mirroring functions are an important aspect of this
mutual regulation process and an emotional scaffolding experi-
ence for the infant (Papousek and Papousek, 1979). In the SSRI+
group, these mirroring functions as judged by affect expression of
the infants may be considered to be different. Fonagy et al. (2002)
explain disturbed reﬂective functions of the mother in being too
uninvolved or too accurate can both be just as devastating for the
infant. Fonagy explains this phenomenon in that, too much pri-
mary experience without modulation overwhelms the infant. This
may be the case with the SSRI+ group.
Mothers from SSRI+ group reacted with negative physical con-
tact in response to infants’ aversion in the free and structured task
situations. On PCERA, negative physical contact can range from
awkward, abrupt and or insensitive handling to intense tickling
and/or rough and tumble play to physical restraint, pinching, hit-
ting. There were no safety or protection concerns raised during
videotaping or detected during coding procedures on any of the
tapes. Although control mothers also reacted negatively to infants’
avoidance and resistance, they were adequately cueing on infant’s
other social behaviors, thus possibly correcting interactive errors.
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It is difﬁcult to speculate why control and SSRI-alone groups’
infants were similar whilst the SSRI+ group infants were react-
ing differently in their affect expression and social behavior pat-
terns. Some plausible explanations include the clinical improve-
ment of mood in SSRI-alone group mothers, unequal burden
of maternal illness in the two experimental, possible neurode-
velopmental stress associated with the combination of SSRIs and
benzodiazepines, as well as variable impact of psychosocial factors.
METHODOLOGICAL LIMITATIONS
There are limitations to this study, which include study speciﬁc
and general difﬁculties in conducting infant research away from a
naturalistic setting; i.e., the constraint of free play whilst videotap-
ing and also the anxiety of attempting an unfamiliar task (Martin
et al., 2002). One study speciﬁc limitation is the small sample size
that limits statistical power in multiple comparison adjustments.
Another limitation is the absence of a third group of untreated
non-psychotropic exposed depressed mother–infant dyads. An
additional issue is the degree to which the ﬁndings may be taken
as being representative of the diagnostic group under scrutiny.
Clinicians who deal with depressed mothers know that it is almost
impossible to obtain a trulymonodiagnostic sample of peripartum
depressed women due to the wide overlapping spectra of the two
affective disorders, i.e., anxiety and depression. The limitations
of measures used also deserve further discussion. For example,
mother–child interaction in videotapes may not accurately depict
the mutual regulation difﬁculties of the dyad that can be picked
up on more sophisticated micro analytic facial expression cod-
ing system or longitudinal examination of relational patterns.
Another limitation is the absence of HAM-Dmeasures for control
group at 8months. In keeping with asymptomatic clinical sta-
tus of control mothers both at 2 and 8months, HAM-D was not
repeated at 8months as similar scores were anticipated. In order
to correlate maternal mood with mutual regulation variables in
all three groups, correlations between mutual regulation variables
8months and HAM-D scores at 2months were calculated for this
group.
CONCLUSION
Despite the limitations, this study has raised clinically relevant
issues. Infants from the SSRI-alone group shared many com-
mon characteristics with the controls, as compared to SSRI+
group of infants, regarding their affect expression patterns. How-
ever, these intra-group differences were not statistically signiﬁ-
cant in infants’ self-regulation capacities. The SSRI-alone (mater-
nal depression) and control mothers may have been cueing to
infants’ affective experiences differently from the SSRI+ group
of mothers (maternal depression with comorbid anxiety disor-
der). The clinical implication of these ﬁndings is not entirely
clear. There is evidence to indicate that comorbid pathology
with maternal depression may be more problematic for mother–
infant dyadic adjustment than the risk conferred by depression
alone (Carter et al., 2001). These mothers usually require com-
binations of psychotropics. There is an urgent need to provide
more supportive networking and insightful therapies such as
cognitive therapies to improve the reﬂective functions of the
mother by targeting mother–infant interactional patterns. Finally,
the head circumferences of control and SSRI+ group infants
were signiﬁcantly larger than those of infants from the SSRI-
alone group (Nulman et al., 1997; Casper et al., 2003); this
ﬁnding needs replication, along with robust neurodevelopmental
data.
CLINICAL IMPLICATIONS
Clinicians who treat anxious and depressed pregnant women face
several ethical and clinical dilemmas. Interventions offered during
pregnancy have to respect mothers and their developing fetuses.
The use of psychotropic medications in pregnancy is considered
to treat moderate to severe maternal mental illness. Untreated
maternal anxiety and depression also confer developmental and
relational risks. This study presents clinically signiﬁcant ﬁnd-
ings regarding affect expression in infants of mothers burdened
with depression and anxiety who received psychotropic medica-
tions during pregnancy. In this study, the longitudinal exami-
nation of control infants and infants exposed to monotherapy
(maternal depression without comorbid anxiety disorder) was
similar in their patterns of self-regulation and affect expression.
A different pattern was evident with infants who were exposed
in utero to a combination of SSRIs and benzodiazepines (comor-
bid maternal depression and anxiety disorder) when compared to
the healthy dyads. This ﬁnding needs to be replicated in studies
with larger sample sizes. Nevertheless, serious clinical implica-
tions of the mixed burden of maternal anxiety and depression and
other potential stressors such as in utero psychotropic medication
exposure should be considered.
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